Skip to main content
Top
Literature
1.
go back to reference Go RS, Winters JL, Kay NE (2017) How I treat autoimmune hemolytic anemia. Blood 129:2971–2979CrossRef Go RS, Winters JL, Kay NE (2017) How I treat autoimmune hemolytic anemia. Blood 129:2971–2979CrossRef
2.
go back to reference Murphy S, LoBuglio AF (1976) Drug therapy of autoimmune hemolytic anemia. Semin Hematol 13:323–334PubMed Murphy S, LoBuglio AF (1976) Drug therapy of autoimmune hemolytic anemia. Semin Hematol 13:323–334PubMed
3.
go back to reference Lafarge A, Bertinchamp R, Pichereau C, Valade S, Chermak A, Theodose I, Canet E, Lemiale V, Schlemmer B, Galicier L, Azoulay E, Mariotte E (2019) Prognosis of autoimmune hemolytic anemia in critically ill patients. Ann Hematol 98:589–594CrossRef Lafarge A, Bertinchamp R, Pichereau C, Valade S, Chermak A, Theodose I, Canet E, Lemiale V, Schlemmer B, Galicier L, Azoulay E, Mariotte E (2019) Prognosis of autoimmune hemolytic anemia in critically ill patients. Ann Hematol 98:589–594CrossRef
4.
go back to reference Barcellini W (2015) Immune hemolysis: diagnosis and treatment recommendations. Semin Hematol 52:304–312CrossRef Barcellini W (2015) Immune hemolysis: diagnosis and treatment recommendations. Semin Hematol 52:304–312CrossRef
5.
go back to reference Guppy M, Greiner E, Brand K (1993) The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes. Eur J Biochem 212:95–99CrossRef Guppy M, Greiner E, Brand K (1993) The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes. Eur J Biochem 212:95–99CrossRef
Metadata
Title
The Characteristics of AIHA Patients Benefited from Glucocorticoid Treatment
Authors
Shijun Li
Yuan Li
Publication date
01-04-2020
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 2/2020
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-019-01224-4

Other articles of this Issue 2/2020

Indian Journal of Hematology and Blood Transfusion 2/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine